An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
about
A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization.Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation.Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature.Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine lifeUpdate on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.Extracellular proteases as targets for drug developmentCarboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDiscordant fibrin formation in hemophilia.Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?Thrombin generation, fibrin clot formation and hemostasisInsights into thrombin activatable fibrinolysis inhibitor function and regulation.Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.In vivo regulation of plasminogen function by plasma carboxypeptidase B.The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complexStabilization versus inhibition of TAFIa by competitive inhibitors in vitro.Plasma thrombin-activatable fibrinolytic inhibitor (TAFI) among healthy subjects and patients with vascular diseases: a validation study.Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor.Characterizing the Tick Carboxypeptidase Inhibitor
P2860
Q33209290-CFC5E4CB-1CC7-4BD3-89B7-79789FA0E775Q33467391-1E1D1868-1E1E-40C1-B267-1222F961016EQ34007678-1A2D8D98-AC13-4550-A707-9A3F916793ABQ34101751-7BD2A448-79F4-412A-8407-1C1D61D8F9F1Q34391045-26D7A80A-AFDA-4375-9665-A3B4E3D6D4A2Q34786346-67CB4F76-553A-48BD-9BB5-446C0B7A0D0AQ35109940-5AF94E36-C1D6-4897-8C85-DCAD2A482FE8Q35116202-1CFA160C-C7AD-4524-9E33-080880D9281CQ35208114-0226AB4F-8007-45AC-A9AA-C907392086B8Q35752611-8665442B-E36D-4789-A7DB-D7CD7A86D43BQ36105820-FEDF4838-120A-4DE6-A3E3-9E87374CD348Q36384872-CBD80F0A-74B4-431F-AAAC-3D2A98A74763Q36606627-12FE221D-7B2F-475A-A2DB-1C2A414CE15EQ36691794-F01549D6-85E9-4B24-A9AB-773B149220C5Q38117742-A61679B3-D76B-47F8-8B74-9BC0DC4FC561Q38353746-35F3672A-0B61-494F-B934-87969DB7A026Q39739972-1879E147-5342-477C-8972-687336E0429AQ39906372-E58C8AE8-A79F-412B-8CBF-9B36EF48A8A9Q44365963-5BB99D13-5690-45FD-B0F8-BA126238D590Q49080002-A0ED0696-9BFF-4DFC-B7F1-273A0ACCA5DAQ55333995-F7F1FF30-60D9-471F-B8D3-99AA521A1D96Q57956897-1594B8BF-9C03-452A-9D55-B032E3F949EB
P2860
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An inhibitor of activated thro ...... gular vein thrombolysis model.
@ast
An inhibitor of activated thro ...... gular vein thrombolysis model.
@en
type
label
An inhibitor of activated thro ...... gular vein thrombolysis model.
@ast
An inhibitor of activated thro ...... gular vein thrombolysis model.
@en
prefLabel
An inhibitor of activated thro ...... gular vein thrombolysis model.
@ast
An inhibitor of activated thro ...... gular vein thrombolysis model.
@en
P2093
P1433
P1476
An inhibitor of activated thro ...... gular vein thrombolysis model.
@en
P2093
Nagashima M
Verhallen P
P304
P356
10.1016/S0049-3848(00)00184-5
P577
2000-05-01T00:00:00Z